¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"latent porphyria"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent hyperopia
    Àẹ¿ø½Ã
  • latent immunization
    ÀáÀç¸é¿ªÈ­
  • latent infection
    Àẹ°¨¿°
  • latent jaundice
    ÀáÀçȲ´Þ
  • latent nystagmus
    Àẹ´«¶³¸², Àẹ¾ÈÁø
  • latent pacemaker
    µý°÷¹Úµ¿Á¶À²±â, À̼Ҽº½ÉÀå¹Úµ¿Á¶À²±â
  • latent period
    1. ÀáÀç±â 2. Àẹ±â
  • latent phage
    ÀáÀçÆÄÁö
  • latent phase
    1. ÀáÀç±â 2. Àẹ±â
  • latent schizophrenia
    ÀáÀçÁ¤½ÅºÐ¿­º´
  • latent stage
    ÀáÀç±â, Àẹ±â
  • latent strabismus
    Àẹ»ç½Ã
  • latent syphilis
    Àẹ¸Åµ¶
  • latent tetany
    ÀẹÅן´Ï
  • latent time
    Àẹ½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent hyperopia
    Àẹ¿ø½Ã
  • latent immunization
    ÀáÀç¸é¿ªÈ­
  • latent infection
    Àẹ°¨¿°
  • latent jaundice
    ÀáÀçȲ´Þ
  • latent
    Àẹ-, ÀáÀç-
  • latent nystagmus
    Àẹ´«¶³¸², Àẹ¾ÈÁø
  • latent pacemaker
    (¢¡ectopic pacemaker) À̼Ҽº½É¹Úµ¿Á¶À²±â, µý°÷¹Úµ¿Á¶À²±â
  • latent period
    Àẹ±â
  • latent phage
    ÀáÀçÆÄÁö
  • latent schizophrenia
    ÀáÀçÁ¤½ÅºÐ¿­º´
  • latent stage
    Àẹ±â
  • latent strabismus
    Àẹ»ç½Ã
  • latent syphilis
    Àẹ¸Åµ¶
  • latent tetany
    Àẹ°­Á÷
  • latent time
    Àẹ½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • porphyria cutanea tarda
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ
  • porphyria cutanea tarda =PCT ³ª
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ.
  • porphyria cutanea tarda =pct ³ª
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ(¡­ñø)
  • porphyria erythropo(i)etica ³ª
    ÀûÇ÷±¸Áõ½Ä¼º Æ÷¸£ÇǸ°Áõ.
  • porphyria erythropo(i)etica ³ª
    ÀûÇ÷±¸Áõ½Ä¼º(îåúìϹñòãÖàõ) Æ÷¸£ÇǸ°Áõ
  • porphyria hepatica ³ª
    °£¼º(ÊÜàõ)Æ÷¸£ ÇǸ°Áõ.
  • porphyria hepatica ³ª
    °£¼º(ÊÜàõ)Æ÷¸£ÇǸ°Áõ
  • porphyria variegata
    ¾ó·è Æ÷¸£ÇǸ°Áõ
  • porphyria variegata ³ª
    ¹Ý¹®»óÆ÷¸£ÇǸ®¾Æ.
  • porphyria variegata ³ª
    ¹Ý¹®»ó(ÚèÚ£ßÒ)Æ÷¸£ÇǸ®¾Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hereditary porphyria
    À¯Àü¼º Æ÷¸£ÇǸ°Áõ.
  • hereditary porphyria cutanea tarda
    À¯Àü¼º ¸¸¹ß¼º ÇǺΠÆ÷¸£ÇǸ°Áõ
  • mixed porphyria
    º¹ÇÕ Æ÷¸£ÇǸ°Áõ
  • porphyria
    Æ÷¸£ÇǸ°Áõ(¡­ñø).
  • porphyria
    Æ÷¸£ÇǸ°Áõ(¡­ñø)
  • porphyria
    Æ÷¸£ÇǸ°Áõ
  • porphyria cutanea tarda
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ
  • porphyria cutanea tarda =PCT ³ª
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ.
  • porphyria cutanea tarda =pct ³ª
    ¸¸¹ßÇÇºÎÆ÷¸£ÇǸ°Áõ(¡­ñø)
  • porphyria erythropo(i)etica ³ª
    ÀûÇ÷±¸Áõ½Ä¼º Æ÷¸£ÇǸ°Áõ.
  • porphyria erythropo(i)etica ³ª
    ÀûÇ÷±¸Áõ½Ä¼º(îåúìϹñòãÖàõ) Æ÷¸£ÇǸ°Áõ
  • porphyria hepatica ³ª
    °£¼º(ÊÜàõ)Æ÷¸£ ÇǸ°Áõ.
  • porphyria hepatica ³ª
    °£¼º(ÊÜàõ)Æ÷¸£ÇǸ°Áõ
  • porphyria variegata
    ¾ó·è Æ÷¸£ÇǸ°Áõ
  • porphyria variegata ³ª
    ¹Ý¹®»óÆ÷¸£ÇǸ®¾Æ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ANLI antibody-negative with latent infection
CLV cassava latent virus; constant linear velocity
EL early latent; elbow; electroluminescence; erythroleukemia; exercise limit; external lamina
HL hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph...
Hl hypermetropia, latent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LI Latent Inhibition
LMP Latent Membrane Protein
LMP-1 Latent Membrane Protein 1
LTBP Latent TGF-beta binding protein
LMP1 Latent infection membrane protein 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • latent heat of fusion
    À¶ÇØ Àá¿­
    ¹°ÁúÀÌ ³ì´Â °úÁ¤¿¡¼­ ¿ÂµµÀÇ º¯È­¸¦ ¼ö¹ÝÇÏÁö ¾Ê°í Èí¼ö ¶Ç´Â ¹æÃâµÇ´Â ¿­·®.
  • latent image
    ˇȗ
    »çÁø¿¡¼­, ³ëÃâÇÑ ÈÄ ¾ÆÁ÷ Çö»óÇÏÁö ¾ÊÀº Çʸ§ÀÇ °¨±¤¸· °¡¿îµ¥ ÀÖ´Â ÇÇ»çüÀÇ ¿µ»ó.
  • latent myofascial trigger point
    ÀáÀ缺 ±Ù¸· ¹ßÅëÁ¡
    ÃËÁø¿¡ ÀÇÇØ ÅëÁõÀÌ ³ªÅ¸³ª´Â °ÍÀ» Æ÷ÇÔÇÏ¿© Ȱµ¿¼º ±Ù¸· ¹ßÅëÁ¡ÀÇ ¸ðµç Ư¼ºÀ» °¡ÁöÁö¸¸ Àڹ߼ºÀÇ ÀÓ»óÀû ÅëÁõÀ̳ª Áõ»óÀÇ ¿øÀÎÀÌ µÇÁö´Â ¾Ê´Â ±Ù¸· ¹ßÅëÁ¡.
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ ±â°£
    ¿Ü°ü»ó ºÒȰ¼ºÈ­ µÈ ±â°£. Á¶Á÷ÀÌ À¯ÇØ ¹°Áú¿¡ ³ëÃâ µÈ °Í°ú ¹ÝÀÀÀÌ ÀϾ±â±îÁöÀÇ »çÀÌ ¶Ç´Â Áï°¢ÀûÀÎ Àڱذú ¹ÝÀÀÀÇ ½ÃÀÛ »çÀÌÀÇ ±â°£.
  • latent prostatic cancer
    Àü¸³»ù ÀáÀç ¾Ï
  • latent schizophrenia
    Àẹ ºÐ¿­º´
    1. Á¤½Åº´ÀûÀÎ Á¤½ÅºÐ¿­º´ÀÇ ±â¿Õ·ÂÀº ¾øÀ¸³ª Á¤½ÅºÐ¿­º´¿¡ °É¸± °¨¼ö¼ºÀÌ ÀÖ´Â °Í. 2. Á¤½ÅºÐ¿­ÁõÀÇ ±âº»ÀûÀÎ Áõ»óÀº Á¸ÀçÇϰí ÀÖÀ¸³ª ºÐ¸íÇÑ Á¤½Åº´ Áõ»óÀ¸·Î Ç¥¸éÈ­Çϰųª »çȸ»ýȰÀÇ ºÎÀûÀÀÀ» ÃÊ·¡ÇÏÁö ¾Ê´Â °Í.
  • latent state
    ÀáÀç »óÅÂ
    Àẹ±âÀÇ ±ÕÀÇ »óÅÂ. ±Õ ÀÚ½ÅÀÇ º´Àû Ư¼ºÀ» ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖ´Â »óÅÂ.
  • latent trigger point
    ÀáÀ缺 ¹ßÅëÁ¡
  • latent zone
    Àẹ´ë
    ¼¼±ÕÀÇ ÀÏ»ý¿¡¼­ Àẹ±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hepatic porphyria A category of porphyria that includes porphyria cutanea tarda, variegate porphyria, and coproporphyria.
Synonym: porphyria hepatica.
(05 Mar 2000)
hepatoerythropoietic porphyria An autosomal recessive disorder in which there is a deficiency or absence of uroporphyrinogen decarboxylase; results in photosensitivity and excessive hepatic production of 8-and 7-carboxylate porphyrins.
(05 Mar 2000)
South African type porphyria Porphyria characterised by abdominal pain and neuropsychiatric abnormalities, by dermal sensitivity to light and mechanical trauma, by increased faecal excretion of proto-and coproporphyrin, and by increased urinary excretion of d-aminolevulinic acid, porphobilinogen, and porphyrins; due to a deficiency of protoporphyrinogen oxidase; autosomal dominant inheritance.
Synonym: protocoproporphyria hereditaria, South African type porphyria.
(05 Mar 2000)
squirrel porphyria Porphyria as an apparently normal metabolic state seen in the Florida fox squirrel (Sciurus niger).
(05 Mar 2000)
d-aminolevulinate dehydratase porphyria An inherited disorder in which there is a deficiency of porphobilinogen synthase; d-aminolevulinate levels are elevated, leading to neurological disturbances.
Synonym: porphobilinogen synthase porphyria.
(05 Mar 2000)
swine porphyria Porphyria as a dominant trait seen in swine.
(05 Mar 2000)
symptomatic porphyria A form of hepatic porphyria (porphyria, hepatic) characterised by photosensitivity resulting in bullae that rupture easily to form shallow ulcers. This condition occurs in two forms: a sporadic, nonfamilial form that begins in middle age and has normal amounts of uroporphyrinogen decarboxylase with diminished activity in the liver; and a familial form in which there is an autosomal dominant inherited deficiency of uroporphyrinogen decarboxylase in the liver and red blood cells.
(12 Dec 1998)
intermittent acute porphyria <gastroenterology, haematology> A group of rare inherited metabolic disorders that result from a disturbance in porphyrin metabolism, causing increased formation and excretion of porphyrin or its precursors.
It is caused by hepatic overproduction of d-aminolevulinic acid, which has greatly increased urinary excretion and of porphobilinogen, and some increase of uroporphyrin, due to a deficiency of porphobilinogen deaminase.
Clinical features: intermittent acute attacks of hypertension, abdominal colic, psychosis, and polyneuropathy, but with no photosensitivity.
It is exacerbated by the ingestion of certain drugs such as; barbiturates).
Inheritance: autosomal dominant.
(20 Sep 2002)
ovulocyclic porphyria Acute episodic exacerbations of porphyria occurring in the premenstrual period.
(05 Mar 2000)
erythropoietic porphyria A classification of porphyria that includes congenital erythropoietic porphyria and erythropoietic protoporphyria.
(05 Mar 2000)
early latent syphilis Infection with Treponema pallidum, the organism of syphilis, after the primary and secondary phases have subsided, during the first year after infection, before any manifestations of tertiary syphilis have appeared.
(05 Mar 2000)
late latent syphilis Usually infectious in pregnant women only, who may pass the infection on to the foetus.
(05 Mar 2000)
latent Dormant. A state that some cancer cells might assume. (Opp: growing or active).
(16 Dec 1997)
latent adrenocortical insufficiency Adrenocortical insufficiency not clinically evident but which can become severe if a sudden stress, such as an intercurrent acute illness, develops.
(05 Mar 2000)
latent allergy Allergy that causes no signs or symptoms but can be revealed by means of certain immunologic tests with specific allergens.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á